Company · CIK 0001444192
Grace Therapeutics, Inc.
GRCESearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$1.89−$0.06 (−3.08%)
GRCE · Last trade
- Prev close
- $1.95
- Range (29d)
- $1.89 – $2.16
On the record
Recent filings
- 8-KGRCECurrent report0001140361-26-037114 · 150.6 KBSEC(opens sec.gov)
- SCHEDULE 13G/AGRCEGrace Therapeutics, Inc.0001104659-26-097338 · 13.7 KBSEC(opens sec.gov)
- SCHEDULE 13G/AGRCEGrace Therapeutics, Inc.0001104659-26-097290 · 11.2 KBSEC(opens sec.gov)
- 8-KGRCECurrent report0001140361-26-032644 · 312.6 KBSEC(opens sec.gov)
- 10-QGRCEQuarterly update0001140361-26-032632 · 4.4 MBSEC(opens sec.gov)
- SCHEDULE 13GGRCEGrace Therapeutics, Inc.0001493152-26-036565 · 23.3 KBSEC(opens sec.gov)
- 8-KGRCECurrent report0001140361-26-031671 · 696.2 KBSEC(opens sec.gov)
- 8-KGRCECurrent report0001140361-26-029837 · 6.8 MBSEC(opens sec.gov)
- 8-KGRCECurrent report0001140361-26-025669 · 6.8 MBSEC(opens sec.gov)
- 8-KGRCECurrent report0001140361-26-025667 · 333.3 KBSEC(opens sec.gov)
Insiders
- ADAR1 Capital Management, LLC10% Owner
- ADAR1 Partners, LP10% Owner
- Boily Jean-FrancoisVICE-PRESIDENT, FINANCE
- Canan JohnDirector
- Carter Roderick NoelDirector
- D'Alvise JanelleDirector, PRESIDENT & CEO
- D'Andrea CarrieVP Clinical Operations
- DAVIS A BRIANDirector
- DelAversano Robert JPrincipal Financial Officer
- Derby MichaelDirector
Tickers
Addresses
business
103 CARNEGIE CENTER SUITE 300
PRINCETON, NJ, 08540
mailing
103 CARNEGIE CENTER SUITE 300
PRINCETON, NJ, 08540
Former names
- Acasti Pharma Inc.2024-10-25
Same industry